Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality

Leuk Res. 2013 Oct;37(10):1229-32. doi: 10.1016/j.leukres.2013.07.014. Epub 2013 Aug 6.

Abstract

Hyperammonemia attributed to multiple myeloma (MM) has been rarely reported. We present 6 patients from our institution and 34 from the literature with MM-induced hyperammonemic encephalopathy. The median age was 67 years with male:female ratio of 1.8:1. The median ammonia level was 114 umol/L. IgG and IgA MM was seen in 40% and 35% of cases, respectively. The in-patient mortality was 48%. The in-patient mortality was 31% in patients who received MM-directed therapy and 100% in those who did not received MM-directed therapy. Hyperammonemic encephalopathy is a rare complication in MM and is associated with high in-patient mortality.

Keywords: Ammonia; Encephalopathy; Myeloma.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Diseases / etiology*
  • Brain Diseases / mortality*
  • Female
  • Humans
  • Hyperammonemia / complications*
  • Hyperammonemia / etiology*
  • Male
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / pathology
  • Neoplasm Staging
  • Retrospective Studies
  • Young Adult